Heaf James
Department of Medicine, Zealand University Hospital, Roskilde, Denmark.
Clin Kidney J. 2017 Apr;10(2):149-153. doi: 10.1093/ckj/sfw150. Epub 2017 Feb 18.
The incidence of end-stage renal disease (ESRD) continues to vary substantially between the countries in Europe that contribute data to the ERA-EDTA Registry. Differences can be attributed to socioeconomic factors and prophylaxis programs for patients with chronic kidney disease (CKD) and may also express real differences in CKD incidence. Recently, age-adjusted ESRD incidence has begun to fall in many countries, probably related to improved prophylaxis. However, absolute rates may increase, partly due to socioeconomic advances in countries with a low gross domestic product and partly due to continuing increases in the proportion of elderly patients. Prevalence rates are expected to continue to increase, mainly due to increases in relative transplant prevalence, improved graft survival times and continuing improvements in both dialysis and transplant patient survival. Overall treatment results continue to improve.
向欧洲肾脏协会-欧洲透析与移植协会（ERA-EDTA）登记处提供数据的欧洲国家中，终末期肾病（ESRD）的发病率仍存在很大差异。这些差异可归因于社会经济因素以及针对慢性肾脏病（CKD）患者的预防计划，也可能反映出CKD发病率的实际差异。最近，许多国家经年龄调整的ESRD发病率已开始下降，这可能与预防措施的改善有关。然而，绝对发病率可能会上升，部分原因是国内生产总值较低国家的社会经济进步，部分原因是老年患者比例持续增加。预计患病率将继续上升，主要原因是相对移植患病率增加、移植物存活时间延长以及透析和移植患者生存率持续提高。总体治疗效果持续改善。
